KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Free Cash Flow (2016 - 2025)

Eli Lilly's Free Cash Flow history spans 17 years, with the latest figure at $677.9 million for Q4 2025.

  • For Q4 2025, Free Cash Flow fell 30.66% year-over-year to $677.9 million; the TTM value through Dec 2025 reached $9.0 billion, up 138.62%, while the annual FY2025 figure was $9.0 billion, 138.62% up from the prior year.
  • Free Cash Flow reached $677.9 million in Q4 2025 per LLY's latest filing, down from $6.7 billion in the prior quarter.
  • In the past five years, Free Cash Flow ranged from a high of $6.7 billion in Q3 2025 to a low of -$1.4 billion in Q4 2023.
  • Average Free Cash Flow over 5 years is $1.3 billion, with a median of $1.2 billion recorded in 2022.
  • Peak YoY movement for Free Cash Flow: skyrocketed 1025.79% in 2021, then plummeted 219.02% in 2023.
  • A 5-year view of Free Cash Flow shows it stood at $2.0 billion in 2021, then crashed by 41.02% to $1.2 billion in 2022, then tumbled by 219.02% to -$1.4 billion in 2023, then skyrocketed by 170.69% to $977.7 million in 2024, then plummeted by 30.66% to $677.9 million in 2025.
  • Per Business Quant, the three most recent readings for LLY's Free Cash Flow are $677.9 million (Q4 2025), $6.7 billion (Q3 2025), and $1.4 billion (Q2 2025).